The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.

Also called NCT04408430

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Mayra Guerrero (from the registry)
Registry
  • NCT NCT04408430
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Mexico (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04408430. Non-randomized; no masking; primary purpose treatment. Start 2021-03-08 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Acronym
MITRAL-II
Condition
Mitral Annular Calcification
Condition
Mitral Stenosis
Condition
Mitral Regurgitation
Condition
Mitral Valve Disease
Intervention (Device)
Transseptal ViMAC
Lead sponsor
Mayra Guerrero (class: other)

Record details

Record id
cardio:ct-nct04408430
Content hash
e6ea7319c5b2cffe06ec97bf7932ee127947c4b5690bb46edc2d1f3b75cdced9